Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Sep;42(3):370-7.
doi: 10.1038/bjc.1980.247.

Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in hong kong: a necropsy study: 1963-1976

Free PMC article

Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in hong kong: a necropsy study: 1963-1976

J B Gibson et al. Br J Cancer. 1980 Sep.
Free PMC article

Abstract

Hepatitis B surface antigen (HBsAg) was stained in liver tissue in 71% of 496 cases of cirrhosis with and without hepatocellular carcinoma (HCC) in Chinese coming to necropsy in Hong Kong from 1963-1976. Male cases numbered 417; HBsAg was positive in 83% of those in which HCC was combined with cirrhosis and in 62% of those with cirrhosis alone. Of 39 additional male cases of HCC without cirrhosis, 38% were HBsAg+. Similar proportions were recorded in the famale cases. This progression suggests a cumulative carcinogenic effect of persistent hepatitis B virus (HBV) fully expressed in the presence of cirrhosis. The approximate risk factors for males in Hong Kong who are HBsAg+ at the time of death, compared with HBsAg- males, are 6:1 for HCC alone, 16:1 for cirrhosis alone and 50:1 for HCC combined with cirrhosis. The frequency of HBsAg+ tests is much higher in Hong Kong than in the United Kingdom, and cirrhosis is calculated to be 2.8 times and HCC 11 times commoner. The high incidence of HCC in Hong Kong is not attributable solely to the high incidence of cirrhosis, but can be related to the high incidence of cirrhosis accompanied by persistent HBV.

PubMed Disclaimer

References

    1. Recent Results Cancer Res. 1972;39:107-18 - PubMed
    1. J Clin Pathol. 1973 Dec;26(12):936-42 - PubMed
    1. Jpn J Exp Med. 1974 Feb;44(1):25-36 - PubMed
    1. J Clin Pathol. 1974 Aug;27(8):669-82 - PubMed
    1. Lab Invest. 1975 Jul;33(1):88-95 - PubMed

Substances